Although studies evaluating cNF Skindex have consistently demonstrated that visibility of cNF lesions is associated with negative effects on QoL, dedicated validation for its use in studies in NF1-associated cNF is lacking. The gene discussed is NPHS1; the disease is neurofibromatosis type 1.